Aug 12 (Reuters) - Cynapsus Therapeutics Inc CTH.TO :
* APL-130277 was safe and generally well-tolerated with no discontinuations because of adverse events
* Announces publication in journal Movement Disorders of data for treatment of OFF episodes in patients with parkinson's disease
* Results suggests APL-130277 rapidly and effectively converts patients from off to full on state Source text for Eikon: ID:nGNXMZIEAa Further company coverage: CTH.TO